top of page
Kids1.2.png
Galileo-Biosystems-Logo-v3 white transparent.png

Our Mission

Our mission at Galileo Biosystems is to expedite the development of innovative treatments for serious inflammatory diseases by navigating the complexities of the immune system. We strive to bring solutions to patients, addressing unmet medical needs and improving their quality of life. Through our unwavering commitment, cutting-edge research, and efficient translation of scientific discoveries, we aim to revolutionize the treatment landscape and provide hope to individuals living with these challenging conditions.

Our Team

The Galileo team is a highly experienced, knowledgeable and passionate group of professionals with over 50 years of combined experience in developing novel therapies. Their dedication to advancing the science of drug development has been a cornerstone of their success

Mike.jpeg

Co-Founder

Michael D. Howell, PhD

Pharmaceutical executive and translational research leader responsible for the advancement of 8+ novel clinical therapies across immunological, autoimmune & inflammatory diseases

  • LinkedIn
Ed.jpeg

Co-Founder

Eduardo Esquenazi, PhD

Founder & CEO of Sirenas, inventor of computational metabolomics platform, Biotech/tech investor

​

​

  • LinkedIn
Tamara.jpeg

Co-Founder

Tamara Schwent

Strategic and operational leader with experience managing cross-functional teams and external relationships to drive innovation and drug discovery programs

​

  • LinkedIn

Our Advisors

Jay Hagan.jpg

Jay Hagan

CEO

​Regulus Therapeutics

JamesMackay.jpeg

James Mackay, PhD

CEO 

Aristea Therapeutics

Phil.jpeg

Phil Baran, PhD

Chair, Dept of Chemistry 

Scripps Research Institute

©2023 by Galileo Biosystems Inc.

bottom of page